Claude Huriez Hospital

Lille 59037

0 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Chronic Hepatitis C Infection, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Chronic Myelomonocytic Leukemia (CMML), Diffuse Large B-cell Lymphoma (DLBCL), MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome, Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma, Metastatic Castration-Resistant Prostate Cancer, Multiple Myeloma

Studies at this site

• A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies — Completed
• Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment — Running, not enrolling
• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
• TL-895 and KRT-232 Study in Acute Myeloid Leukemia — Status unconfirmed
• A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed